Inactive Instrument

Transcripts Adamas Pharmaceuticals, Inc.

Equities

ADMS

US00548A1060

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

Transcript : Adamas Pharmaceuticals, Inc., Q2 2021 Earnings Call, Aug 09, 2021	21-08-09
Transcript : Adamas Pharmaceuticals, Inc. Presents at BofA Securities 2021 Virtual Health Care Conference, May-11-2021 11:45 AM	21-05-11
Transcript : Adamas Pharmaceuticals, Inc., Q1 2021 Earnings Call, May 10, 2021	21-05-10
Transcript : Adamas Pharmaceuticals, Inc. Presents at Cowen 41st Annual Health Care Conference, Mar-02-2021 02:50 PM	21-03-02
Transcript : Adamas Pharmaceuticals, Inc., Q4 2020 Earnings Call, Feb 23, 2021	21-02-23
Transcript : Adamas Pharmaceuticals, Inc. - Special Call	21-02-01
Adamas Pharmaceuticals, Inc. Provides Revenues Guidance for the Fourth Quarter and Full Year 2020	21-01-13	CI
Transcript : Adamas Pharmaceuticals, Inc. Presents at H.C. Wainwright BioConnect 2021 Conference, Jan-11-2021 06:00 AM	21-01-11
Transcript : Adamas Pharmaceuticals, Inc., Q3 2020 Earnings Call, Nov 05, 2020	20-11-05
Transcript : Adamas Pharmaceuticals, Inc., Q2 2020 Earnings Call, Aug 06, 2020	20-08-06
Transcript : Adamas Pharmaceuticals, Inc., Q1 2020 Earnings Call, May 07, 2020	20-05-07
Transcript : Adamas Pharmaceuticals, Inc., Q4 2019 Earnings Call, Feb 25, 2020	20-02-25
Adamas Pharmaceuticals, Inc. Provides Preliminary Consolidated Sales Guidance for GOCOVRI for the Fourth Quarter and Full Year Ended December 31, 2019; Expects to Engage with the FDA in the First Half of 2020 to Discuss a Potential Regulatory Pathway for ADS-5102 for Multiple Sclerosis Patients	20-01-08	CI
Transcript : Adamas Pharmaceuticals, Inc., Q3 2019 Earnings Call, Nov 07, 2019	19-11-07
Transcript : Adamas Pharmaceuticals, Inc., Q2 2019 Earnings Call, Aug 08, 2019	19-08-08
Transcript : Adamas Pharmaceuticals, Inc. Presents at Bank of America Merrill Lynch 2019 Healthcare Conference, May-15-2019 10:40 AM	19-05-15
Transcript : Adamas Pharmaceuticals, Inc., Q1 2019 Earnings Call, May 09, 2019	19-05-09
Transcript : Adamas Pharmaceuticals, Inc., Q4 2018 Earnings Call, Mar 04, 2019	19-03-04
Adamas Pharmaceuticals, Inc. Provides Preliminary Consolidated Sales Guidance for GOCOVRI for the Fourth Quarter and Full Year Ended December 31, 2018; Expects the Completion of Enrollment for the Phase 3 Inroads Study of ADS-5102	19-01-06	CI
Transcript : Adamas Pharmaceuticals, Inc. Presents at 27th Annual Credit Suisse Healthcare Conference, Nov-14-2018 02:50 PM	18-11-14

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Transcripts Adamas Pharmaceuticals, Inc.

Equities

ADMS

US00548A1060

Transcripts

Filters